Back to today’s briefing

Story perspectives

FNM Secures WHO Approval, Boosts Mozambique's Medicine Production

8/2/2025

35 3

Summary

Story summary

At the MIH EXPO 2025, the National Medicines Factory (FNM) proudly highlighted its strides in Mozambique's pharmaceutical landscape. With the prestigious WHO Prequalification Certificate, FNM is on a mission to reduce imports and deliver high-quality medicines. Its subsidiary, INFARMA, boosts production capabilities, including vaccines, reinforcing Mozambique's health independence and global standing.

1 of 1

Story summary

At the MIH EXPO 2025, the National Medicines Factory (FNM) proudly highlighted its strides in Mozambique's pharmaceutical landscape. With the prestigious WHO Prequalification Certificate, FNM is on a mission to reduce imports and deliver high-quality medicines. Its subsidiary, INFARMA, boosts production capabilities, including vaccines, reinforcing Mozambique's health independence and global standing.